54th Annual Montrose Fall Clinics

Dr. Matt Luther is Associate Professor at Vanderbilt Medical Center. He is director of the Vanderbilt Comprehensive Hypertension Center, where he evaluates and treats resistant and secondary causes of hypertension such as primary aldosteronism and renovascular hypertension. He is board certified in Internal Medicine and Nephrology and is a certified Hypertension Specialist. He is co-editor of the recent "Hypertension Secrets," 2nd ed. and serves as an education editor for the journal "Hypertension".

Amrut Ambardekar, MD is a Professor of Medicine and Cardiology at the University of Colorado. He is the Section Head of Advanced Heart Failure-Transplant Cardiology and has served as the Medical Director of the Cardiac Transplant Program since 2014. He also founded and directs the Cardiac Amyloidosis Program at the University of Colorado. His translational research program studies the cardiac and vascular effects of non-pulsatile flow from continuous-flow LVADs and aims to reduce LVAD complications. He has participated in multiple clinical trials investigating new pharmacologic and device therapies for patients with advanced heart failure and cardiac amyloidosis.

Dr. Rurak earned his undergraduate degree at the University of Pennsylvania in Philadelphia, graduating with a BA in Health & Societies and a concentration in international health. Remaining in Philadelphia, he pursued his medical education at Jefferson Medical College, followed by residency at Drexel University/Hahnemann Hospital. He then moved to New York City where he completed his pulmonary and critical care fellowship at Mount Sinai Hospital.

During his fellowship, Dr. Rurak developed a deep interest in pulmonary physiology, exercise, and pulmonary hypertension. Seeking to expand his expertise, he completed a three-month elective at National Jewish Health as a fellow, immersing himself further in these specialized areas.

Following the completion of his fellowship, Dr. Rurak joined the faculty at Mount Sinai Hospital. In his first year on faculty, he returned to National Jewish Health to enhance his proficiency in pulmonary physiology and CPET interpretation. This experience proved invaluable as he assumed the role of co-director of the CPET Lab at Mount Sinai, where he played a pivotal role in rebuilding the CPET program that had been temporarily paused during the COVID-19 pandemic.

In March, Dr. Rurak transitioned to join the faculty at National Jewish Health as part of the pulmonary hypertension team. His clinical and research interests encompass pulmonary hypertension, pulmonary embolism, dyspnea, pulmonary physiology, and exercise testing.

Originally from Denver, Colorado, Erin Finn completed her undergraduate studies at Rice University in biochemistry and earned her medical degree at the University of Colorado. She returned to Houston for an Internal Medicine–Pediatrics residency at Baylor College of Medicine before heading back to Colorado for fellowship training. She completed dual fellowships in Pediatric Endocrinology and (adult) Endocrinology, Metabolism, and Diabetes at the University of Colorado.

Dr. Finn remained at the University of Colorado as an Assistant Professor in the Departments of Pediatrics and Internal Medicine, splitting her time between UCHealth Anschutz and Children’s Hospital Colorado. In addition to practicing general endocrinology, her interests include chronic endocrine conditions of childhood, youth-onset type 2 diabetes, and the transition of care between pediatric and adult healthcare systems. She is a founder of the Young Adult Diabetes Clinic at the UCHealth Anschutz Endocrine Clinic and the LEAP (Lifestyle Medicine 2 Emerging Adult Program) in the youth-onset type 2 diabetes clinic at CHCO.

When not in clinic or the hospital, she is an avid vegetable gardener, an amateur potter, and a pretty decent skier. She lives in Denver with her husband, Lucas, and their rescue dog, Pepper.

Dr. Matt Luther is Associate Professor at Vanderbilt Medical Center. He is director of the Vanderbilt Comprehensive Hypertension Center, where he evaluates and treats resistant and secondary causes of hypertension such as primary aldosteronism and renovascular hypertension. He is board certified in Internal Medicine and Nephrology and is a certified Hypertension Specialist. He is co-editor of the recent "Hypertension Secrets," 2nd ed. and serves as an education editor for the journal "Hypertension".

Dr. Rurak earned his undergraduate degree at the University of Pennsylvania in Philadelphia, graduating with a BA in Health & Societies and a concentration in international health. Remaining in Philadelphia, he pursued his medical education at Jefferson Medical College, followed by residency at Drexel University/Hahnemann Hospital. He then moved to New York City where he completed his pulmonary and critical care fellowship at Mount Sinai Hospital.

During his fellowship, Dr. Rurak developed a deep interest in pulmonary physiology, exercise, and pulmonary hypertension. Seeking to expand his expertise, he completed a three-month elective at National Jewish Health as a fellow, immersing himself further in these specialized areas.

Following the completion of his fellowship, Dr. Rurak joined the faculty at Mount Sinai Hospital. In his first year on faculty, he returned to National Jewish Health to enhance his proficiency in pulmonary physiology and CPET interpretation. This experience proved invaluable as he assumed the role of co-director of the CPET Lab at Mount Sinai, where he played a pivotal role in rebuilding the CPET program that had been temporarily paused during the COVID-19 pandemic.

In March, Dr. Rurak transitioned to join the faculty at National Jewish Health as part of the pulmonary hypertension team. His clinical and research interests encompass pulmonary hypertension, pulmonary embolism, dyspnea, pulmonary physiology, and exercise testing.

Originally from Denver, Colorado, Erin Finn completed her undergraduate studies at Rice University in biochemistry and earned her medical degree at the University of Colorado. She returned to Houston for an Internal Medicine–Pediatrics residency at Baylor College of Medicine before heading back to Colorado for fellowship training. She completed dual fellowships in Pediatric Endocrinology and (adult) Endocrinology, Metabolism, and Diabetes at the University of Colorado.

Dr. Finn remained at the University of Colorado as an Assistant Professor in the Departments of Pediatrics and Internal Medicine, splitting her time between UCHealth Anschutz and Children’s Hospital Colorado. In addition to practicing general endocrinology, her interests include chronic endocrine conditions of childhood, youth-onset type 2 diabetes, and the transition of care between pediatric and adult healthcare systems. She is a founder of the Young Adult Diabetes Clinic at the UCHealth Anschutz Endocrine Clinic and the LEAP (Lifestyle Medicine 2 Emerging Adult Program) in the youth-onset type 2 diabetes clinic at CHCO.

When not in clinic or the hospital, she is an avid vegetable gardener, an amateur potter, and a pretty decent skier. She lives in Denver with her husband, Lucas, and their rescue dog, Pepper.

Amrut Ambardekar, MD is a Professor of Medicine and Cardiology at the University of Colorado. He is the Section Head of Advanced Heart Failure-Transplant Cardiology and has served as the Medical Director of the Cardiac Transplant Program since 2014. He also founded and directs the Cardiac Amyloidosis Program at the University of Colorado. His translational research program studies the cardiac and vascular effects of non-pulsatile flow from continuous-flow LVADs and aims to reduce LVAD complications. He has participated in multiple clinical trials investigating new pharmacologic and device therapies for patients with advanced heart failure and cardiac amyloidosis.